| Stage | ITT | % of rev | CDRE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $203M | 100.00% | ITT ×7.26 |
| Gross profit | $510M | 34.63% | $88M | 43.42% | CDRE +8.8pp |
| Operating income | $180M | 12.24% | $28M | 13.97% | CDRE +1.7pp |
| Pre-tax income | $135M | 9.18% | $24M | 11.80% | CDRE +2.6pp |
| Net income | $87M | 5.87% | $16M | 7.88% | CDRE +2.0pp |
| Stage | ITT | CDRE | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $203M100.00% | ITT ×7.26 |
| Gross profit | 34.63%$510M | 43.42%$88M | CDRE +8.8pp |
| Operating income | 12.24%$180M | 13.97%$28M | CDRE +1.7pp |
| Pre-tax income | 9.18%$135M | 11.80%$24M | CDRE +2.6pp |
| Net income |
| 5.87%$87M |
| 7.88%$16M |
| CDRE +2.0pp |
No shared counterparties.